Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | y014868 | OT |
No additional AEs were reported; a patient received improperly stored vaccine; This spontaneous report was received from a certified medical assistant (C.M.A.) and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-APR-2025, the was vaccinated with improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) solution for injection (lot #y014868, expiration date: 03-SEP-2026) (exact dose, dose number, route of administration and anatomical location was not provided), for prophylaxis (Product storage error). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) solution for injection (lot# and expiry date were not reported). On an unknown date, the vaccine underwent a temperature excursion of 5.5 Fahrenheit degrees up to 14.4 Fahrenheit degrees for 40 minutes and 14.5 Fahrenheit degrees up to 46.4 Fahrenheit degrees/15.8 Fahrenheit degrees for 10 minutes. There was no previous temperature excursion. No additional adverse events were reported.
Sterile diluent